China Pharma Holdings, Inc. (CPHI) - NYSEMKT
  • Tue, May 17, 9:34 AM
    • China Pharma (CPHI +3.9%) Q1 results: Revenues: $3.6M (-36.8%); Operating Expense: $1.4M (-12.5%); Operating Loss: ($1.3M) (+65.8%); Net Loss: ($1.6M) (+61.0%); Loss Per Share: ($0.04) (+55.6%); Quick Assets: $42.3M (-18.0%); CF Ops: $1.3M.
    • No guidance given.
    | Tue, May 17, 9:34 AM
  • Tue, May 17, 6:07 AM
    • China Pharma (NYSEMKT:CPHI): Q1 EPS of -$0.04
    • Revenue of $3.64M (-36.0% Y/Y)
    • Press Release
    | Tue, May 17, 6:07 AM
  • Thu, Mar. 31, 6:41 AM
    • China Pharma Holdings (CPHI) FY15 results: Revenues: $20.4M (-7.7%); R&D Expense: $1M (-64.3%); SG&A: $6.2M (+21.6%); Operating Loss: ($14.3M) (+63.1%); Net Loss: ($15.4M) (+61.1%); Loss Per Share: ($0.35) (+61.5%); Quick Assets: $6.2M (+17.0%).
    • No guidance given.
    | Thu, Mar. 31, 6:41 AM
  • Thu, Mar. 31, 6:04 AM
    • China Pharma (NYSEMKT:CPHI): FY15 EPS of -$0.35
    • Revenue of $20.35M (-8.0% Y/Y)
    • Press Release
    | Thu, Mar. 31, 6:04 AM
  • Nov. 17, 2015, 6:58 AM
    • China Pharma Holdings (CPHI -8.3%) Q3 results: Revenues: $4.5M (-19.6%); R&D Expense: $0.4M (+100.0%); SG&A: $1.5M (+25.0%); Operating Loss: ($3.9M) (+35.0%); Net Loss: ($4.1M) (+34.9%); Loss Per Share: ($0.10) (+33.3%); Quick Assets: $5.7M (+7.5%).
    • No guidance given.
    | Nov. 17, 2015, 6:58 AM
  • Nov. 17, 2015, 6:08 AM
    • China Pharma (NYSEMKT:CPHI): Q3 EPS of -$0.10
    • Revenue of $4.48M (-19.6% Y/Y)
    | Nov. 17, 2015, 6:08 AM
  • Aug. 14, 2015, 7:18 AM
    • China Pharma Holdings (CPHI) Q2 results: Revenues: $5.7M (-6.6%); COGS: $4.5M (+21.6%); R&D Expense: $0.2M (-89.5%); SG&A: $1.5M (+50.0%); Operating Loss: ($3.8M) (+55.3%); Net Loss: ($4.1M) (+52.3%); Loss Per Share: ($0.09) (+55.0%); Quick Assets: $4.5M (-15.1%).
    • No guidance given.
    | Aug. 14, 2015, 7:18 AM
  • Aug. 14, 2015, 6:03 AM
    • China Pharma (NYSEMKT:CPHI): Q2 EPS of -$0.09
    • Revenue of $5.7M (-6.6% Y/Y)
    | Aug. 14, 2015, 6:03 AM
  • May 12, 2015, 6:02 AM
    • China Pharma (NYSEMKT:CPHI): Q1 EPS of -$0.18
    • Revenue of $5.7M (-19.7% Y/Y)
    | May 12, 2015, 6:02 AM
  • Mar. 31, 2015, 6:44 AM
    • China Pharma Holdings (CPHI -13.8%) FY14 results: Revenues: $24.9M (-24.1%); COGS: $17.2M (-26.5%); R&D Expense: $2.8M (+64.7%); SG&A: $5.1M (-10.5%); Operating Loss: ($25.3M) (-36.0%); Net Loss: ($26M) (-30.0%); Loss Per Share: ($0.60) (-30.4%); Quick Assets: $5.3M (-11.7%); CF Ops: $4.6M (-46.5%).
    • No guidance given.
    | Mar. 31, 2015, 6:44 AM
  • Mar. 31, 2015, 6:03 AM
    • China Pharma (NYSEMKT:CPHI): FY14 EPS of -$0.60
    • Revenue of $24.9M (-24.1% Y/Y)
    | Mar. 31, 2015, 6:03 AM
  • Nov. 14, 2014, 8:05 AM
    • China Pharma Holdings (CPHI +3.4%) Q3 results: Revenues: $5.6M (-30.9%); COGS: $4.1M (-30.5%); R&D Expense: $0.2M (-50.0%); SG&A: $1.2M (-7.7%); Operating Loss: ($6M) (-122.2%); Net Loss: ($6.3M) (-173.9%); Loss Per Share: ($-0.15) (-200.0%); Quick Assets: $4.3M (-28.3%); CF Ops: $2.6M (-29.7%).
    • No guidance given.
    | Nov. 14, 2014, 8:05 AM
  • Nov. 14, 2014, 6:04 AM
    • China Pharma (NYSEMKT:CPHI): Q3 EPS of -$0.15
    • Revenue of $5.56M (-31.4% Y/Y)
    | Nov. 14, 2014, 6:04 AM
  • Aug. 15, 2014, 7:25 AM
    • China Pharma Holdings (NYSEMKT:CPHI) Q2 results: Revenues: $6.1M (-23.6%); Operating Expenses: $10.9M (+58.4%); Net Loss: ($8.6M) (-93.6%); Loss Per Share: ($0.20) (-100.0%); Quick Assets: $4.4M (-26.2%); CF Ops (1H): $2.4M (-21.1%).
    • No financial guidance given.
    | Aug. 15, 2014, 7:25 AM
  • Aug. 15, 2014, 6:04 AM
    • China Pharma (NYSEMKT:CPHI): Q2 EPS of -$0.20
    • Revenue of $6.1M (-23.8% Y/Y)
    | Aug. 15, 2014, 6:04 AM
Company Description
China Pharma Holdings, Inc. engages in the development, manufacturing, packaging, marketing and distribution of generic and branded pharmaceutical products for a range of high incidence and high mortality conditions. The company focuses on its therapeutics include CNS, cardiovascular,... More
Sector: Healthcare
Industry: Drug Manufacturers - Major
Country: China